Onlay mesh placement of the synthetic and fully resorbable TIGR®Matrix surgical mesh (Novus Scientific AB, Uppsala -- Sweden) for the prevention of incisional hernia in septic patients undergoing emergency laparoscopy showed encouraging efficacy and safety in a small retrospective study, as presented during the XXVIII Waterford Surgical October Club Meeting.
©invincible7 / 123RF Stock Photo
©European Society for Medical Oncology
©American Society for Clinical Oncology (ASCO)
©American Association for Cancer Research
©Chinese Society for Anesthesiology
© European Society for Medical Oncology
©sherryyates / 123RF Stock Photo
An interim analysis of the Phase III IMpower132 study showed that atezolizumab (Tecentriq®, Roche/Genentech) plus platinum-based chemotherapy (cisplatin or carboplatin) with pemetrexed improves the median progression-free survival (PFS) in treatment-naïve patients with non-squamous non-small cell lung cancer (NSCLC). The median PFS for atezolizumab plus pemetrexed and a platinum salt was 7.6 months vs 5.2 months with chemotherapy alone (HR=0.60, 95% CI: 0.49-0.72; p<0.0001).
Prof. Kessler began by explaining that the topic of how regional anaesthesia should be performed has always been an intense and somewhat emotional discussion. Should it be performed in awake, sedated and/or anaesthetised patients? He asked the audience how many of them routinely perform peripheral nerve blocks in the anaesthetised patient; around 20% said yes.
© Copyright – MediPaper Medical Communications – Medical Communications & Health News
MediPR | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | Medical Communications Health Blog | Medical Writer Jobs | MediNews.asia | Anaesthesiology.asia